Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 571.87 Delayed Data As of Oct 21 |  -4.23 / -0.73%Today’s Change | 294.86 Today|||52-Week Range 664.64 | +52.30% Year-to-Date |
Latest REGN News | Press Releases
Today’s Trading
| Previous close | 576.63 |
| Today’s open | 577.53 |
| Day’s range | 567.02 - 581.68 |
| Volume | 493,964 |
| Average volume (3 months) | 890,323 |
| Market cap | $63.8B |
Data as of 4:00pm ET, 10/21/2020
Growth & Valuation
| Earnings growth (last year) | -14.46% |
| Earnings growth (this year) | +19.36% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +17.18% |
| P/E ratio | 22.1 |
| Price/Sales | 5.47 |
| Price/Book | 5.96 |
Competitors
Data as of 7:37pm ET, 10/21/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | $7.01 |
| Annual revenue (last year) | $7.9B |
| Annual profit (last year) | $2.1B |
| Net profit margin | 26.91% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
